(Q38086083)

28 August 2017

title

Mesenchymal stem cells secretome: a new paradigm for central nervous system regeneration? (English)

1 reference

28 August 2017

main subject

mesenchymal stem cell

1 reference

0 references

1 reference

3

1 reference

28 August 2017

Fábio Gabriel Teixeira

object named as

Fábio G Teixeira

series ordinal

1

0 references

Antonio J. Salgado

object named as

António J Salgado

series ordinal

4

0 references

author name string

Miguel M Carvalho

series ordinal

2

1 reference

28 August 2017

publication date

1 March 2013

1 reference

Cellular and Molecular Life Sciences

28 August 2017

published in

1 reference

28 August 2017

volume

70

1 reference

28 August 2017

issue

20

1 reference

28 August 2017

page(s)

3871-3882

1 reference

https://scigraph.springernature.com/pub.10.1007/s00018-013-1290-8

28 August 2017

exact match

0 references

cites work

Progress and prospects: stem cells and neurological diseases

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Stem cells in human neurodegenerative disorders--time for clinical translation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Clinical translation of stem cells in neurodegenerative disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

The stem cell niche should be a key issue for cell therapy in regenerative medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Homing of endogenous stem/progenitor cells for in situ tissue regeneration: Promises, strategies, and translational perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Prospects for translational regenerative medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Mesenchymal stem cells: cell biology and potential use in therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Mesenchymal stem cells hold promise for regenerative medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Neuroprotective features of mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Human adipose tissue is a source of multipotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Multilineage cells from human adipose tissue: implications for cell-based therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Human placenta-derived cells have mesenchymal stem/progenitor cell potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Phenotypic and functional characterization of mesenchymal stem cells from chorionic villi of human term placenta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Mesenchymal progenitor cells in human umbilical cord blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Stem cells in the umbilical cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

The adult human brain harbors multipotent perivascular mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Mechanisms involved in the therapeutic properties of mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Biochemical heterogeneity of mesenchymal stem cell populations: clues to their therapeutic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Matrix cells from Wharton's jelly form neurons and glia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Directed differentiation of motor neuron cell-like cells from human adipose-derived stem cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Mapping of the secretome of primary isolates of mammalian cells, stem cells and derived cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Optimizing mesenchymal stem cell-based therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Mesenchymal stem cell secreted vesicles provide novel opportunities in (stem) cell-free therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Functional delivery of viral miRNAs via exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Neuroprotective mesenchymal stem cells are endowed with a potent antioxidant effect in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Mesenchymal stem cells as trophic mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Characterization of conditioned medium of cultured bone marrow stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Human bone marrow-derived mesenchymal stem cells secrete brain-derived neurotrophic factor which promotes neuronal survival in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

The secretome of bone marrow mesenchymal stem cells-conditioned media varies with time and drives a distinct effect on mature neurons and glial cells (primary cultures).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Multiple neurogenic and neurorescue effects of human mesenchymal stem cell after transplantation in an experimental model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Brain and spinal cord affected by amyotrophic lateral sclerosis induce differential growth factors expression in rat mesenchymal and neural stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Adipose tissue derived stem cells secretome: soluble factors and their roles in regenerative medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Adipose-derived mesenchymal stem cells protect PC12 cells from glutamate excitotoxicity-induced apoptosis by upregulation of XIAP through PI3-K/Akt activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

AMP-activated kinase mediates adipose stem cell-stimulated neuritogenesis of PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

IFATS collection: The conditioned media of adipose stromal cells protect against hypoxia-ischemia-induced brain damage in neonatal rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

The secretome of stem cells isolated from the adipose tissue and Wharton jelly acts differently on central nervous system derived cell populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

The conditioned medium of murine and human adipose-derived stem cells exerts neuroprotective effects against experimental stroke model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Adipose-derived stem cells stimulate regeneration of peripheral nerves: BDNF secreted by these cells promotes nerve healing and axon growth de novo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Implantation of human umbilical cord-derived mesenchymal stem cells as a neuroprotective therapy for ischemic stroke in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Role of human umbilical cord mesenchymal progenitors conditioned media in neuronal/glial cell densities, viability, and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Enhancement of neuroplasticity through upregulation of beta1-integrin in human umbilical cord-derived stromal cell implanted stroke model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Stem cell therapy for cerebral ischemia: from basic science to clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Functional recovery after transplantation of bone marrow-derived human mesenchymal stromal cells in a rat model of spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Phenotype analysis in patients with early onset Parkinson's disease with and without parkin mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

The role of neuroinflammation on the pathogenesis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Advances in the treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Levodopa-associated increase of homocysteine levels and sural axonal neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Transplantation of fetal dopamine neurons in Parkinson's disease: one-year clinical and neurophysiological observations in two patients with putaminal implants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Transplantation of fetal dopamine neurons in Parkinson's disease: PET [18F]6-L-fluorodopa studies in two patients with putaminal implants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Mesenchymal stem cells for treatment of CNS injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Stem cell transplantation: a promising therapy for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Regenerative effect of neural-induced human mesenchymal stromal cells in rat models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Autologous transplants of Adipose-Derived Adult Stromal (ADAS) cells afford dopaminergic neuroprotection in a model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopaminergic neurons in vitro: potential therapeutic application for Parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Dopaminergic differentiation of human mesenchymal stem cells--utilization of bioassay for tyrosine hydroxylase expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Mesenchymal stem cell transplantation attenuates blood brain barrier damage and neuroinflammation and protects dopaminergic neurons against MPTP toxicity in the substantia nigra in a model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Intravenous administration of mesenchymal stem cells exerts therapeutic effects on parkinsonian model of rats: focusing on neuroprotective effects of stromal cell-derived factor-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Protective effects of neurotrophic factor-secreting cells in a 6-OHDA rat model of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Transplantation of undifferentiated human mesenchymal stem cells protects against 6-hydroxydopamine neurotoxicity in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Levodopa/dopamine replacement strategies in Parkinson's disease--future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Potential of rat bone marrow-derived mesenchymal stem cells as vehicles for delivery of neurotrophins to the Parkinsonian rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Cellular and paracellular transplants for spinal cord injury: a review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

What is the potential of oligodendrocyte progenitor cells to successfully treat human spinal cord injury?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Pharmacological interventions for spinal cord injury: where do we stand? How might we step forward?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Bone marrow stromal cell transplantation for treatment of sub-acute spinal cord injury in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Transplantation of human umbilical mesenchymal stem cells from Wharton's jelly after complete transection of the rat spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Concise review: Bone marrow for the treatment of spinal cord injury: mechanisms and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

BDNF-expressing marrow stromal cells support extensive axonal growth at sites of spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Axon growth and recovery of function supported by human bone marrow stromal cells in the injured spinal cord exhibit donor variations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Transplantation of bone marrow mesenchymal stem cells reduces lesion volume and induces axonal regrowth of injured spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Human mesenchymal stem cell-derived Schwann cell-like cells exhibit neurotrophic effects, via distinct growth factor production, in a model of spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Cografted Wharton's jelly cells-derived neurospheres and BDNF promote functional recovery after rat spinal cord transection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

An in vivo characterization of trophic factor production following neural precursor cell or bone marrow stromal cell transplantation for spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Cellular treatments for spinal cord injury: the time is right for clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

A comparison between neurally induced bone marrow derived mesenchymal stem cells and olfactory ensheathing glial cells to repair spinal cord injuries in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Cell replacement therapy: helping the brain to repair itself

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Inflammation after stroke: mechanisms and therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Treatment of acute ischemic stroke: beyond thrombolysis and supportive care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Stem cell therapy in stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Therapeutic time window of mesenchymal stem cells derived from bone marrow after cerebral ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Early transient presence of implanted bone marrow stem cells reduces lesion size after cerebral ischaemia in adult rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Therapeutic benefits of human mesenchymal stem cells derived from bone marrow after global cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

SDF-1alpha/CXCR4-mediated migration of systemically transplanted bone marrow stromal cells towards ischemic brain lesion in a rat model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Adipose-derived mesenchymal stem cells markedly attenuate brain infarct size and improve neurological function in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

IFATS collection: in vivo therapeutic potential of human adipose tissue mesenchymal stem cells after transplantation into mice with liver injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Transplanted bone marrow stromal cells migrate, differentiate and improve motor function in rats with experimentally induced cerebral stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Adult stem cell transplantation in stroke: its limitations and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Growth factors in ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Defining human mesenchymal stem cell efficacy in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Mesenchymal stem cells for the treatment of neurodegenerative disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Mesenchymal stem cells: new approaches for the treatment of neurological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Bone marrow-derived mesenchymal stem cell therapy as a candidate disease-modifying strategy in Parkinson's disease and multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Differentiation potential of human postnatal mesenchymal stem cells, mesoangioblasts, and multipotent adult progenitor cells reflected in their transcriptome and partially influenced by the culture conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Bone marrow-derived mesenchymal stem cells for the treatment of ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Contralesional axonal remodeling of the corticospinal system in adult rats after stroke and bone marrow stromal cell treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Enhancing trophic support of mesenchymal stem cells by ex vivo treatment with trophic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Mesenchymal stem cells for ischemic stroke: changes in effects after ex vivo culturing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Mesenchymal stem cells promote oligodendroglial differentiation in hippocampal slice cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Mesenchymal stromal cells: facilitators of successful transplantation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1290-8

Transplantation of human mesenchymal stem cells promotes functional improvement and increased expression of neurotrophic factors in a rat focal cerebral ischemia model

21 January 2018

1 reference

12 December 2020

1 reference

12 December 2020

Bone marrow stromal cells for spinal cord repair: a challenge for contemporary neurobiology

1 reference

12 December 2020

Cell-based therapeutic approaches for Parkinson's disease: progress and perspectives

1 reference

12 December 2020

Adipose-derived mesenchymal stromal/stem cells: tissue localization, characterization, and heterogeneity

1 reference

12 December 2020

NT-3-secreting human umbilical cord mesenchymal stromal cell transplantation for the treatment of acute spinal cord injury in rats

1 reference

12 December 2020

Advances in the diagnosis, treatment, and understanding of Parkinson's disease and parkinsonism

1 reference

12 December 2020

Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells

1 reference

12 December 2020

Intrastriatal grafts of mesenchymal stem cells in adult intact rats can elevate tyrosine hydroxylase expression and dopamine levels

1 reference

12 December 2020

Bone marrow stromal cells stimulate neurite outgrowth over neural proteoglycans (CSPG), myelin associated glycoprotein and Nogo-A

1 reference

12 December 2020

Clinical safety and primary efficacy of bone marrow mesenchymal cell transplantation in subacute spinal cord injured patients

1 reference

12 December 2020

Spinal cord injury treatment with intrathecal autologous bone marrow stromal cell transplantation: the first clinical trial case report

1 reference

12 December 2020

Adult neurotrophic factor-secreting stem cells: a potential novel therapy for neurodegenerative diseases.

1 reference

12 December 2020

Effect of human mesenchymal stem cell transplantation combined with growth factor infusion in the repair of injured spinal cord.

1 reference

12 December 2020

Bone marrow stromal cells can achieve cure of chronic paraplegic rats: functional and morphological outcome one year after transplantation

1 reference

12 December 2020

Autologous mesenchymal stem cell transplantation in stroke patients

1 reference

12 December 2020

Transdifferentiation potentiality of human Wharton's jelly stem cells towards vascular endothelial cells

1 reference

12 December 2020

Role of mesenchymal stem cells in neurogenesis and nervous system repair

1 reference

12 December 2020

Bone marrow stromal cells as replacement cells for Parkinson's disease: generation of an anatomical but not functional neuronal phenotype

1 reference

12 December 2020

Multipotent stromal cells are activated to reduce apoptosis in part by upregulation and secretion of stanniocalcin-1.

1 reference

12 December 2020

Administration of cultured autologous bone marrow stromal cells into cerebrospinal fluid in spinal injury patients: a pilot study

1 reference

12 December 2020

Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method

1 reference

12 December 2020

Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction

1 reference

12 December 2020

Transplantation of predifferentiated adipose-derived stromal cells for the treatment of spinal cord injury

1 reference

12 December 2020

10.1007/S00018-013-1290-8

Identifiers

DOI

1 reference

28 August 2017

1 reference